Reeves L - Search Results

1

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.

Kohn DB, Booth C, Shaw KL, Xu-Bayford J, Garabedian E, Trevisan V, Carbonaro-Sarracino DA, Soni K, Terrazas D, Snell K, Ikeda A, Leon-Rico D, Moore TB, Buckland KF, Shah AJ, Gilmour KC, De Oliveira S, Rivat C, Crooks GM, Izotova N, Tse J, Adams S, Shupien S, Ricketts H, Davila A, Uzowuru C, Icreverzi A, Barman P, Campo Fernandez B, Hollis RP, Coronel M, Yu A, Chun KM, Casas CE, Zhang R, Arduini S, Lynn F, Kudari M, Spezzi A, Zahn M, Heimke R, Labik I, Parrott R, Buckley RH, Reeves L, Cornetta K, Sokolic R, Hershfield M, Schmidt M, Candotti F, Malech HL, Thrasher AJ, Gaspar HB. Kohn DB, et al. Among authors: reeves l. N Engl J Med. 2021 May 27;384(21):2002-2013. doi: 10.1056/NEJMoa2027675. Epub 2021 May 11. N Engl J Med. 2021. PMID: 33974366 Free PMC article. Clinical Trial.

2

Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease.

Urbinati F, Wherley J, Geiger S, Fernandez BC, Kaufman ML, Cooper A, Romero Z, Marchioni F, Reeves L, Read E, Nowicki B, Grassman E, Viswanathan S, Wang X, Hollis RP, Kohn DB. Urbinati F, et al. Among authors: reeves l. Cytotherapy. 2017 Sep;19(9):1096-1112. doi: 10.1016/j.jcyt.2017.06.002. Epub 2017 Jul 18. Cytotherapy. 2017. PMID: 28733131

3

Clinical retroviral vector production: step filtration using clinically approved filters improves titers.

Reeves L, Cornetta K. Reeves L, et al. Gene Ther. 2000 Dec;7(23):1993-8. doi: 10.1038/sj.gt.3301328. Gene Ther. 2000. PMID: 11175310

4

Production of retroviral vectors for clinical use.

Cornetta K, Reeves L, Cross S. Cornetta K, et al. Among authors: reeves l. Methods Mol Biol. 2008;433:17-32. doi: 10.1007/978-1-59745-237-3_2. Methods Mol Biol. 2008. PMID: 18679615

5

Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors.

Chen J, Reeves L, Cornetta K. Chen J, et al. Among authors: reeves l. Hum Gene Ther. 2001 Jan 1;12(1):61-70. doi: 10.1089/104303401450979. Hum Gene Ther. 2001. PMID: 11177543

6

Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.

Reeves L, Smucker P, Cornetta K. Reeves L, et al. Hum Gene Ther. 2000 Oct 10;11(15):2093-103. doi: 10.1089/104303400750001408. Hum Gene Ther. 2000. PMID: 11044911

7

Detection of ecotropic replication-competent retroviruses: comparison of s(+)/l(-) and marker rescue assays.

Reeves L, Duffy L, Koop S, Fyffe J, Cornetta K. Reeves L, et al. Hum Gene Ther. 2002 Sep 20;13(14):1783-90. doi: 10.1089/104303402760293619. Hum Gene Ther. 2002. PMID: 12396630

8

Partnership between CTSI and business schools can promote best practices for core facilities and resources.

Reeves L, Dunn-Jensen LM, Baldwin TT, Tatikonda MV, Cornetta K. Reeves L, et al. Clin Transl Sci. 2013 Aug;6(4):297-302. doi: 10.1111/cts.12059. Epub 2013 Apr 19. Clin Transl Sci. 2013. PMID: 23919365 Free PMC article.

9

Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.

Chen J, Reeves L, Sanburn N, Croop J, Williams DA, Cornetta K. Chen J, et al. Among authors: reeves l. Virology. 2001 Mar 30;282(1):186-97. doi: 10.1006/viro.2001.0826. Virology. 2001. PMID: 11259201 Free article.

10

Vector production in an academic environment: a tool to assess production costs.

Boeke A, Doumas P, Reeves L, McClurg K, Bischof D, Sego L, Auberry A, Tatikonda M, Cornetta K. Boeke A, et al. Among authors: reeves l. Hum Gene Ther Methods. 2013 Feb;24(1):49-57. doi: 10.1089/hgtb.2012.213. Hum Gene Ther Methods. 2013. PMID: 23360377 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page